Structure–Activity Relationships of cyclo(l-Tyrosyl-l-tyrosine) Derivatives Binding to Mycobacterium tuberculosis CYP121: Iodinated Analogues Promote Shift to High-Spin Adduct

Journal of Medicinal Chemistry
2019.0

Abstract

A series of analogues of cyclo(l-tyrosyl-l-tyrosine), the substrate of the Mycobacterium tuberculosis enzyme CYP121, have been synthesized and analyzed by UV-vis and electron paramagnetic resonance spectroscopy and by X-ray crystallography. The introduction of iodine substituents onto cyclo(l-tyrosyl-l-tyrosine) results in sub-μM binding affinity for the CYP121 enzyme and a complete shift to the high-spin state of the heme FeIII. The introduction of halogens that are able to interact with heme groups is thus a feasible approach to the development of next-generation, tight binding inhibitors of the CYP121 enzyme, in the search for novel antitubercular compounds.

Knowledge Graph

Similar Paper

Structure–Activity Relationships of cyclo(<scp>l</scp>-Tyrosyl-<scp>l</scp>-tyrosine) Derivatives Binding to Mycobacterium tuberculosis CYP121: Iodinated Analogues Promote Shift to High-Spin Adduct
Journal of Medicinal Chemistry 2019.0
Design, synthesis and evaluation against Mycobacterium tuberculosis of azole piperazine derivatives as dicyclotyrosine (cYY) mimics
Bioorganic &amp; Medicinal Chemistry 2018.0
Synthesis and biological evaluation of novel cYY analogues targeting Mycobacterium tuberculosis CYP121A1
Bioorganic &amp; Medicinal Chemistry 2019.0
Fragment-Based Approaches to the Development ofMycobacterium tuberculosisCYP121 Inhibitors
Journal of Medicinal Chemistry 2016.0
Novel Aryl Substituted Pyrazoles as Small Molecule Inhibitors of Cytochrome P450 CYP121A1: Synthesis and Antimycobacterial Evaluation
Journal of Medicinal Chemistry 2017.0
Synthesis, biological evaluation and computational studies of pyrazole derivatives as Mycobacterium tuberculosis CYP121A1 inhibitors
RSC Medicinal Chemistry 2022.0
A new strategy for hit generation: Novel in cellulo active inhibitors of CYP121A1 from Mycobacterium tuberculosis via a combined X-ray crystallographic and phenotypic screening approach (XP screen)
European Journal of Medicinal Chemistry 2022.0
Synthesis and structure activity relationships of cyanopyridone based anti-tuberculosis agents
European Journal of Medicinal Chemistry 2020.0
Antitubercular Nucleosides That Inhibit Siderophore Biosynthesis:  SAR of the Glycosyl Domain
Journal of Medicinal Chemistry 2006.0
SAR and identification of 2-(quinolin-4-yloxy)acetamides as Mycobacterium tuberculosis cytochrome bc<sub>1</sub> inhibitors
MedChemComm 2016.0